Filter Results:
(110)
Show Results For
- All HBS Web
(110)
- News (31)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
Show Results For
- All HBS Web
(110)
- News (31)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he... View Details
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
genome, Goldberg has focused his most recent efforts on explaining the impact of this revolutionary discovery on the agribusiness system. "All industries that deal with living things or organic compounds will have a common language... View Details
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 03 Apr 2007
- First Look
First Look: April 3, 2007
drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and... View Details
Keywords: Martha Lagace
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
to intellectual property, it's clear they realize they don't have to own a discovery to profit from it," Chesbrough remarked. Years ago, Xerox's legendary Palo Alto Research Center (PARC) was the source of such major advances as the... View Details
Keywords: by Jim Aisner
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
countries. Download working paper: http://www.hbs.edu/research/pdf/07-073.pdf Open vs. Integrated Innovation: A Model of Discovery and Confinement Authors:Esteve Almirall and Ramon Casadesus-Masanell Abstract We present a simple formal... View Details
Keywords: Sean Silverthorne
- 01 Oct 2002
- News
Faculty Research Symposium
and asked each of the 177 team members to complete a brief electronic diary every day during the course of a creative project. “We wanted to observe creativity as it was happening within teams that are supposed to be doing creative work,” explained Amabile. One of the... View Details
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details
- 17 Oct 2006
- First Look
First Look: October 17, 2006
its anatomy, which has worked well in other high-tech sectors, can't handle the fundamental challenges facing drug R&D: profound, persistent uncertainty and high risks rooted in the limited knowledge of human biology; the need for the... View Details
Keywords: Sean Silverthorne
- 01 Jun 2008
- News
A Binary Formula
engine of its economy,” says HBS professor Kent Bowen, organizer of the colloquium. “One way to do that is through science and technology, but we need to know how to get those discoveries into the economy.” To achieve that goal, Bowen and... View Details
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074... View Details
Keywords: Martha Lagace
- 27 Sep 2011
- First Look
First Look: September 27
for new products, services, and entire businesses. It may look like innovators are born, not made. But according to Jeffrey Dyer, Hal Gregersen, and Clay Christensen anyone can become more innovative. How? Master the discovery skills that... View Details
Keywords: Sean Silverthorne
- 25 Oct 2016
- First Look
October 25, 2016
insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and... View Details
Keywords: Sean Silverthorne
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
In 1908, Harvard Business School’s first dean, Edwin Francis Gay, welcomed the School’s inaugural class of 59 students by saying that HBS was challenged with encouraging its students to have the “intellectual respect for business as a profession, with the social... View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
low-key mother, an accomplished scientist whose discoveries had been licensed in a multimillion-dollar deal, was on to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the View Details
- 04 Sep 2019
- News
Deep Dive
ship to launch and recover the submersible. He found a decommissioned US Navy ship laid up in a river in Washington State. The USNS Indomitable was originally built to hunt Soviet submarines at the end of the Cold War and was then used by the US Coast Guard for View Details
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
to know how to get those discoveries into the economy." To achieve that goal, Bowen and others believe that science-based companies require a different kind of leadership. "Since the investment and R&D decisions you make... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
and perhaps even refine them more. There's a growing movement and establishment of nonprofit foundations that are participating in drug discovery efforts. These foundations aren't as concerned about... View Details
Keywords: by Martha Lagace